Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.3.5 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Tian-Ran Chen and 7 co-authors. Institution: Department of Ophthalmology, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong Province, China. Major MEDLINE topics: Diabetic Retinopathy, MicroRNAs, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Vascular Endothelial Growth Factor A. Cited 1 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Retinal endothelial cells (RECs) are key targets of diabetes-induced microvascular complications. HnRNPA2B1 suppresses pathological neovascularization in diabetic retinopathy (DR). Although hnRNPA2B1 suppresses pathological neovascularization, its role in hyperglycemia-induced REC dysfunction remains unclear.
Methods
Primary mouse retinal vascular endothelial cells (mRVECs) under high-glucose (HG) conditions and streptozotocin-induced diabetic mice were analyzed using quantitative real-time PCR (qRT-PCR), Western blotting, RNA immunoprecipitation, immunofluorescence staining, and functional assays (wound healing, Transwell invasion, and tube formation). Co-immunoprecipitation and pharmacological inhibitors were used to validate protein interactions and degradation pathways. Retinal morphology and vascular integrity were assessed using hematoxylin-eosin staining, optical coherence tomography angiography, Evans blue leakage, and trypsin digestion.
Results
HG-induced neddylation mediated hnRNPA2B1 degradation, exacerbating REC dysfunction. Mechanistically, hnRNPA2B1 facilitated miR-93-5p maturation by recruiting DGCR8 within the microprocessor complex, thereby suppressing VEGFA expression via direct targeting of its 3'-untranslated regions. Intravitreal delivery of AAV2-hnRNPA2B1 or miR-93-5p into diabetic mice partially restored retinal hnRNPA2B1/miR-93-5p levels, reduced VEGFA overexpression, and improved retinal histological markers of microvascular damage.
Conclusions
HG-induced effects associated with neddylation pathways lead to hnRNPA2B1 degradation, exacerbating REC dysfunction. HnRNPA2B1, as an RNA binding protein, facilitated miR-93-5p maturation by recruiting DGCR8 within the microprocessor complex. Targeting either hnRNPA2B1 or miR-93-5p may represent a potential therapeutic strategy for preserving retinal vascular homeostasis in diabetes pending functional validation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Qilu Hospital of Shandong University, Shandong University, Jinan, Shandong Province, China.
- School of Medicine, Shandong University, Jinan, Shandong Province, China.
- NHC Key Laboratory of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong Province China.
- Laboratory of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Cite
APA
Chen, T. R., Zhou, J. X., Hou, Y. R., Zhang, Y. N., Li, C. X., Zhu, J., Guo, Z. R., & Cui, Y. (2026). Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.5
Vancouver
Chen TR, Zhou JX, Hou YR, Zhang YN, Li CX, Zhu J, et al. Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.5
BibTeX
@article{Chen2026,
author = {Chen, Tian-Ran and Zhou, Jia-Xing and Hou, Ya-Ru and Zhang, Yun-Nan and Li, Chen-Xi and Zhu, Jing and Guo, Zi-Rui and Cui, Yan},
title = {Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.3.5}
}
EUVIMED